PDO vs PLLA
This page places verifiable specifications side by side. It does not rank materials, score them, or recommend one over another.
Comparison
What is the difference between PDO threads and PLLA?
Both are absorbable polyesters and both travel the same regulatory pathway in Korea and the European Union. What separates them is the form in which they are placed in tissue: one is a continuous strand laid along a plane, the other is mostly a suspension of dispersed particles. One animal study placed both in the same experiment — but it used the thread form of both. Skip that condition and the finding gets carried, wrongly, to injectable PLLA.
| Aspect | PDO (polydioxanone) | PLLA (poly-L-lactic acid) | Basis |
|---|---|---|---|
| Family | Absorbable polyester | Absorbable polyester — the same broad family | — |
| Form in which it is placed in tissue | Monofilament strand; the literature describes barbed, cog and multi-strand constructions | Mostly an injectable particle suspension; thread-form products also appear in the literature | — |
| Whether a mechanical effect is described alongside | Yes — tissue repositioning by an anchored strand is reported together with the biological response | No corresponding item for the injectable form | — |
| Study placing both in one experiment | 30 rats divided into control, cog thread and PLLA thread groups, with biopsies at 1, 3 and 6 months (PMID 30608294) | Same study — both were used in thread form | Legal text |
| What that study reported at 1 month | The difference from control was not statistically significant (p = .245) | Dermal thickness and fibroblast numbers increased relative to control, reported as statistically significant (p = .019) | Legal text |
| What that study reported at 3 and 6 months | Values in the two groups were similar to each other, and both differed significantly from control | Identical | Legal text |
| Regulatory identity — United States | Absorbable sutures listed as devices cleared through the 510(k) pathway (for example K063680) | Injectable implants hold premarket approval PMA P030050, generic name 'implant, dermal, for aesthetic use' | Legal text |
| Items that follow from the form | Extrusion, palpability and asymmetry are reported in the clinical literature | Those items do not arise for a suspension; reconstitution volume and waiting time vary between protocols instead | — |
Same family, different form
The two are close chemical relatives. Both are absorbable polyesters, and both travel the same regulatory pathway in Korea and the European Union. The separation happens at the point of placement.
One is laid along a plane as a continuous strand, so anchoring, extrusion and palpability are the questions that follow. The other is usually dispersed as particles, so reconstitution volume and distribution are the questions that follow. Same chemistry; a different form of placement changes what has to be asked next.
The head-to-head study compared threads
One study placed both materials in the same experiment. It used the thread form of both — a polydioxanone cog thread and a poly-L-lactic acid thread. Injectable PLLA was not in that experiment.
This is not a detail. Most of the literature describing PLLA in this atlas concerns the injectable form, and the injectable and thread forms differ in how they are placed and in the surface area available for degradation. The sentence “an animal study compared PLLA and PDO” points at something other than the fact once that condition is removed.
What the study reported by time point
At one month, a significant increase in dermal thickness and fibroblast number relative to control was reported in the PLLA thread group, while the difference in the cog thread group was not significant at that point. At three and six months the values in the two groups were similar to each other, and both differed significantly from control.
What to hold on to is that this is a finding about timing. It does not weigh the total effect of the two materials against each other; it records that the point at which the observed change appeared differed between the groups. And it is an observation in rat skin across 30 animals.
The regulatory lanes diverge in the United States
In Korea and the European Union both materials travel the device pathway, but in the United States they separate. Absorbable polydioxanone is listed as a suture cleared through the 510(k) pathway; injectable poly-L-lactic acid holds premarket approval as a dermal implant. It is a case of one polymer family entering through different routes according to form and intended use.
Limitations & open questions
The comparative study was carried out in rat skin and used the thread form of both materials. Injectable PLLA was not in that experiment, so the time-point findings above cannot be carried to it. Thread gauge, barb geometry, anchoring method and insertion plane vary between products and operators, and mechanical outcomes depend on all of them, which means clinical reports on the thread side describe technique as much as material. Mechanical and stimulatory effects occur together and are difficult to separate in clinical reporting. No study observing both materials in humans on the same outcome measure was found in the searches behind this page.